(Q37827947)

23 August 2017

Markers of bladder cancer State of the art. (English)

1 reference

23 August 2017

1 reference

Grossman HB

1

1 reference

PubMed ID

21227279

23 August 2017

Dinney CP

series ordinal

2

1 reference

PubMed ID

21227279

23 August 2017

language of work or name

1 reference

1 January 2000

1 reference

23 August 2017

1 reference

23 August 2017

5

1 reference

23 August 2017

1

1 reference

23 August 2017

3-10

1 reference

Current status of urinary cytology in the evaluation of bladder neoplasms

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Reliability of urinary cytodiagnosis in urothelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

The management of clinically unconfirmed positive urinary cytology.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Flow cytometry for detection and evaluation of urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Improved detection of recurrent bladder cancer using the Bard BTA stat Test

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Rapid detection of bladder cancer: a comparative study of point of care tests

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Detection of autocrine motility factor in urine as a marker of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Expression of blood group antigens in bladder cancer: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Prognostic factors in survival of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Use of Lewis X antigen and deoxyribonucleic acid image cytometry to increase sensitivity of urinary cytology in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Carcinoembryonic antigen enhances metastatic potential of human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Carcinoembryonic antigen in serum, urine and cells of patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67).

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Altered patterns of MDM2 and TP53 expression in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Evaluation of epidermal growth factor receptors in bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Integrin VLA-3: ultrastructural localization at cell-cell contact sites of human cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Novel function for beta 1 integrins in keratinocyte cell-cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Molecular detection of primary bladder cancer by microsatellite analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Detection of bladder cancer recurrence by microsatellite analysis of urine

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Telomerase activity: a biomarker of cell proliferation, not malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900002-2

7 January 2021

10.1016/S1078-1439(99)00002-2

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21227279